Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers November 20, 2017
Pharmacy Choice - Pharmaceutical News - Walgreens Pays $9.86 Million Resolving Whistleblower Claims Of Fraud Against California's Medi-Cal Program, Reports Berger & Montague, P.C. - November 20, 2017

Pharmacy News Article

 4/20/17 - Walgreens Pays $9.86 Million Resolving Whistleblower Claims Of Fraud Against California's Medi-Cal Program, Reports Berger & Montague, P.C.

PHILADELPHIA, April 20, 2017 /PRNewswire/ Berger & Montague, P.C. announced today the settlement of a False Claims Act case against Walgreen Co. (Walgreens) for $9.86 million to resolve allegations that Walgreens falsely billed California's Medicaid Program, Medi-Cal. The settlement resolves allegations raised in two whistleblower lawsuits brought under the qui tam provisions of the False Claims Act. Berger & Montague represented former Walgreens pharmacy technician, Debbie G. Rinehart, who was one of the two individuals to report the fraud.

Berger & Montague shareholder Joy Clairmont commented, "Our whistleblower client, a former pharmacy technician who worked at Walgreens for nine years, was also a Medi-Cal beneficiary for a time. As such, she intimately understands the need for integrity in the Medi-Cal Program, and is satisfied to have helped contribute as a relator to this successful resolution."

In 2014, Ms. Rinehart filed her suit under seal pursuant to the provisions of the Federal False Claims Act and California False Claims Act. The lawsuit alleged that Walgreens improperly billed Medi-Cal for certain prescription drugs, "Code 1" drugs, appearing on Medi-Cal's formulary list. As alleged, Walgreens knowingly failed to comply with applicable "Code 1" drug restrictions and documentation requirements by failing to ensure that the drugs were prescribed for the requisite diagnoses prior to dispensing the drugs to Medi-Cal beneficiaries. The United States and the State of California intervened in the action for settlement.

Dan Miller, the co-chair of Berger & Montague's Qui Tam Practice Group, commended the government's investigation and resolution of the case: "We applaud the outstanding efforts of Assistant United States Attorney Catherine J. Swann and her colleagues at the U.S. Attorney's Office in Sacramento as well as California's Bureau of Medicaid Fraud and Elder Abuse who assisted in achieving this settlement."

The lawsuit is captioned United States ex rel. Debbie G. Rinehart v. Walgreen Co., Case No. 2:14-cv-0148 (E.D. Cal.).


Daniel Miller
Shareholder, Berger & Montague, P.C.

Joy Clairmont
Shareholder, Berger & Montague, P.C.

To view the original version on PR Newswire, visit:

SOURCE Berger & Montague, P.C.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Nov 20: Obesity Management: Overview of Pharmacotherapy
Last Chance
Nov 21: Standards of Practice for Filling Controlled Substance Prescriptions in Florida
Last Chance
Nov 22: Medical Marijuana: Examining the Science, Not the Politics
Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement